Biotech

All Articles

Biogen, UCB document phase 3 lupus gain after failing earlier trial

.Biogen as well as UCB's bet one's bottom dollar developing right into stage 3 astride an unsuccessf...

Aptadir hopes new RNA inhibitors may turn around complicated cancers cells

.Italian biotech Aptadir Therapies has launched with the guarantee that its own pipeline of preclini...

Wave surfs DMD results to regulatory authorities' doors, sending out stock up

.Surge Life Sciences has actually fulfilled its own goal in a Duchenne muscular dystrophy (DMD) rese...

Sanofi plucks brand-new CSO coming from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is going back to the pharma layer, occupying the...

Achilles drips cell therapy plan, bandages for unemployments after missing out on 'business viability' targets

.Achilles Therapeutics has actually torn up its technique. The British biotech is knocking off on it...

Aligos declares stage 2 MASH win, lowering liver body fat approximately 46%

.Aligos Therapies is actually proclaiming a midstage gain in metabolic-dysfunction affiliated steato...

Basilea credit ratings $268M BARDA backing for antifungals, anti-biotics

.Basilea Pharmaceutica's job developing brand new antifungals has obtained a significant boost comin...

Capricor sells Europe rights to late-stage DMD therapy for $35M

.Having actually scooped up the USA legal rights to Capricor Therapeutics' late-stage Duchenne muscl...

FDA junks adcomm for Applied's unusual illness medicine

.After dismissing the decision meeting for Applied Therapies' metabolic ailment drug govorestat, the...

Novo inks $600M NanoVation package to analyze genetic medications ex-liver

.Novo Nordisk is proceeding its own press into genetic medicines, accepting to compensate NanoVation...